March 24, 2009--Toyama Chemical Co., Ltd. and Eisai Co., Ltd. announced today that the companies have decided to withdraw temporarily the New Drug Application (NDA) of anti-rheumatic drug T-614 (generic name: iguratimod), which have been developed jointly by the two companies in Japan.
the details can be read here.
No comments:
Post a Comment